Get the Weekly Intelligence Brief — top committee picks every Sunday.
FTV · NYSE · STOCK

Fortive (FTV) Stock Analysis

Technology Updated October 10, 2026
$57.25
52W $47.95 – $64.56
55/100
$17.29B
33.3
0.99
AI Committee Verdict
Watch
55/100
Conviction: Contested · 50% agreement · 6 analysts
+8.9%
-1.6%
5.52:1
Contested

Is FTV Bullish or Bearish?

Mixed. Innellis AI committee rates Fortive (FTV) Watch with a composite score of 55/100 , based on 6 analysts with 50% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +4.90 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -15.10 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.30 across 10 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • News sentiment is positive (+0.30 across 10 articles, 14d) — News
Bear Case
  • P/E of 32.2 is moderate-to-rich — Value
  • Revenue declining -29.8% YoY -- this is not a growth story right now — Growth
  • EPS declining -23.3% YoY despite any revenue growth — Growth
  • Current ratio of 0.71 is tight -- limited short-term liquidity cushion — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
55/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 74%
of 287 Technology peers
Value Analyst neutral
55 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 32.2 is moderate-to-rich
Growth Analyst neutral
50 / 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− Revenue declining -29.8% YoY -- this is not a growth story right now
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Current ratio of 0.71 is tight -- limited short-term liquidity cushion
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
67 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.30 across 10 articles, 14d)
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 55.3 to 55.1.

Analyst-level changes:
  • News Analyst: +1 bullish signal(s).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
58.0
Neutral
MACD Histogram
0.312
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$56.32
Resistance
$62.37
Bollinger %B
0.83
Inside Bands
Price vs Moving Averages
EMA 9
$56.68 Above
EMA 21
$56.60 Above
EMA 50
$57.57 Below
EMA 200
$58.44 Below

Fundamental Analysis

Valuation
69
Growth
82
Profitability
64
Financial Health
66
Cash Flow
70
Valuation
P/E Ratio 33.3×
P/B Ratio 2.87×
PEG Ratio -1.46
Dividend Yield 0.54%
52W High $64.56
52W Low $47.95
Quality & Growth
ROE 897.5%
ROA 493.4%
Gross Margin 6323.1%
Operating Margin 1822.8%
Revenue Growth YoY —
Debt / Equity 0.58
AI Fundamental Assessment
P/E ratio of 33.3 (rich relative to a 15-40x range); Price-to-book of 2.9x; PEG ratio of -1.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 9.0%; Return on assets of 4.9%; Net margin of 12.4%; Gross margin of 63.2%; Current ratio of 1.24 (tight short-term liquidity); Debt-to-equity of 0.58; Free cash flow per share is positive (3.14); Most recent quarter beat estimates by 3.4%; 4 consecutive earnings beats; EPS growth accelerating (-22.2% -> +5.7% QoQ); Average YoY EPS growth of 27.6%; Analyst estimates falling over recent quarters
Get the Full FTV Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime